The mRNA Synthesis Service Market is Entering a New Phase of Innovation by Automation
![]() |
mRNA Synthesis Service Market |
The
m-RNA synthesis Service Market enables rapid development of advanced
therapeutics through cost-effective manufacture of custom designed therapeutic
mRNA. Messenger RNA (mRNA) based therapeutics require efficient synthesis of
large volumes of chemically modified mRNA with high purity. The commercial mRNA
synthesis services offer automated production platforms to simplify customer
workflows and accelerate drug discovery programs. The global m-RNA synthesis
service market is estimated to be valued at US$ 7417.27 Mn in 2024 and is
expected to exhibit a CAGR of 6.7% over the forecast period between 2024 to
2030.
Key players operating in the m-RNA synthesis service market are Huzhou City
Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma,
Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor
Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra
Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients
Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, and Chemfield Cellulose. The
growing demand for personalized therapeutics and recent success of mRNA based
COVID-19 vaccines have accelerated mRNA drug development activities globally.
Further, strategic collaborations between mRNA synthesis players and
biopharmaceutical companies are enabling global expansion of mRNA therapeutics
pipeline.
Key Takeaways
Key players: Huzhou City Linghu Xinwang Chemical is a leading manufacturer of
mRNA synthesis materials. Rayonier Advanced Materials provides cellulose-based
excipients for mRNA encapsulation and delivery. Asahi Kasei Corporation's
automated mRNA production platforms are widely used in mRNA vaccine development
programs.
Growing demand: The success of mRNA-based COVID-19 vaccines and development of
other novel mRNA therapeutics have boosted demand for customized mRNA synthesis
globally. Several biotechnology companies are outsourcing commercial-scale mRNA
manufacturing to specialty service providers.
Global expansion: Major mRNA synthesis companies are establishing manufacturing
facilities worldwide to support large-scale clinical trials and commercial
production. Strategic collaborations between multinational biopharma firms and
local mRNA players are also enhancing global access to novel mRNA drugs.
Market key trends
A key trend in the Global
mRNA Synthesis Service Market Demand is the growing adoption of fully
automated flexible platforms for producing customized mRNA at an industrial
scale. Automated modular systems allow rapid production of various mRNA
payloads for R&D and clinical applications. They facilitate ‘plug-and-play’
composition of distinct synthesis, purification, and analytical equipment
modules. This enables efficient manufacturing of diverse mRNA constructs on
demand and accelerates drug development timelines.
Porter's
Analysis
Threat of new entrants: The threat of new entrants is moderate as significant
capital investment is required to start manufacturing mRNA and provide
customized services for clients. The industry also requires advanced technical
expertise and resources.
Bargaining power of buyers: The bargaining power of buyers is moderate to high
as there are multiple players providing mRNA synthesis services. Buyers can
negotiate on price and quality of services.
Bargaining power of suppliers: The bargaining power of suppliers is low as raw
materials required for mRNA synthesis such as nucleotides and chemical reagents
are cheaply and readily available.
Threat of new substitutes: There is low threat of substitutes as mRNA synthesis
is unique and plays an important role in manufacturing mRNA used in vaccines,
gene therapies and other applications.
Competitive rivalry: The industry sees high competitive rivalry due to presence
of numerous small and large players providing similar services globally.
Players compete on various factors like technology, cost, customization, and
quality.
Geographically, North America region dominates the global m-RNA synthesis
service market in terms of value. This is attributed to presence of major
market players and rapid technological advancements in the region.
Asia Pacific region is expected to be the fastest growing market for m-RNA
synthesis services during the forecast period owing to increase in R&D
expenditure, growing biologics industry and presence of emerging economies like
China and India providing opportunities.
For more insights, Read- m-RNA
Synthesis Service Market
Comments
Post a Comment